These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2431036)

  • 1. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
    Warner JA; MacGlashan DW
    J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V; Spadaro G; Patella V; Marone G
    J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pertussis toxin on mediator release from human basophils.
    Warner JA; Yancey KB; MacGlashan DW
    J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
    Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
    J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
    Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
    Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human basophil releasability. I. Age-related changes in basophil releasability.
    Marone G; Poto S; di Martino L; Condorelli M
    J Allergy Clin Immunol; 1986 Feb; 77(2):377-83. PubMed ID: 2418093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures.
    Schroeder JT; MacGlashan DW; Kagey-Sobotka A; White JM; Lichtenstein LM
    J Immunol; 1994 Aug; 153(4):1808-17. PubMed ID: 7519213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
    Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
    Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics.
    Casolaro V; Galeone D; Giacummo A; Sanduzzi A; Melillo G; Marone G
    Am Rev Respir Dis; 1989 Jun; 139(6):1375-82. PubMed ID: 2471428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on human basophil releasability.
    Marone G; Poto S; Giugliano R; Bonini S
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):103-6. PubMed ID: 2409008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.